{"data":{"id":1823,"citation":"Snyder DS, Tradtrantip L, Yao C, Kurth MJ, Verkman AS.: Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease. J Med Chem, Volume 54 (15), 2011","title":"Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.","doi":"10.1021\/jm200505e","doi_url":"https:\/\/doi.org\/10.1021\/jm200505e","pmid":"21707078","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/21707078\/","year":2011,"journal":"J Med Chem","volume":"54","issue":"15","page":"5468-5477","authors":[{"first_name":"Kurth MJ","last_name":null,"full_name":null},{"first_name":"Snyder DS","last_name":null,"full_name":null},{"first_name":"Tradtrantip L","last_name":null,"full_name":null},{"first_name":"Verkman AS.","last_name":null,"full_name":null},{"first_name":"Yao C","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/1823","landing_page":"https:\/\/molmedb.upol.cz\/publication\/1823","created_at":"2021-01-20T15:35:17.000000Z","updated_at":null}}